Login to Your Account



Financings Roundup

Aiming for NDA, Trius Pads Coffers with $30M Offering

By Jennifer Boggs
Managing Editor

Tuesday, January 22, 2013
With antibiotic candidate tedizolid nearing the finish line, Trius Therapeutics Inc. is shoring up its balance sheet with a $29.9 million public offering, strengthening its position ahead of partnering discussions in Europe.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription